"I will not allow Big Pharma to operate above the law or put their greed ahead of Texans’ well-being," said Paxton.

KVUE's stock performance has suffered from legacy investor selling, management turnover, litigation risks, and a profit ...

Kimberly-Clark (KMB) stock faces risks from the $48.7B Kenvue acquisition, high debt, and weak growth. Learn why analysts ...

Tylenol-maker Kenvue Inc. must comply with a Texas law requiring out-of-state businesses to register with the state or risk ...

Kimberly-Clark is acquiring Kenvue, creating a health and wellness giant with $32 billion in revenue and 10 brands generating ...

A Texas judge has ordered Tylenol-maker Kenvue Inc. and its former parent Johnson & Johnson to register with the Texas Secretary of State or risk being barred from doing business in the state.

Add in the steady cash returns from dividend stocks, and you can further increase your potential total returns. With this in ...

Tylenol-maker Kenvue Inc. must comply with a Texas law requiring out-of-state businesses to register with the state or risk being barred from conducting business in Texas, a judge ruled.

Kenvue (KVUE) keeps drifting lower even after reporting steady revenue and profit growth, which raises a simple question for ...

Kimberly-Clark (Nasdaq: KMB) is acquiring Kenvue (NYSE: KVUE), creating a health and wellness giant with $32 billion in revenue, and 10 brands generating over $1 billion in annual sales each (such as ...

With consumer prices continuing to rise, many older adults are searching for simple ways to save on everyday essentials. Yet ...

Some big US companies want to shift domicile to Nevada and Texas in a move that is upending the world of business law ...